Next Article in Journal
Benzodiazepines Withdrawal: Initial Outcomes and Long-Term Impact on Falls in a French Nursing Home
Next Article in Special Issue
Patient Safety and Pro Re Nata Prescription and Administration: A Systematic Review
Previous Article in Journal
De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary
Previous Article in Special Issue
Clozapine Patients at the Interface between Primary and Secondary Care
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle
Pharmacy 2018, 6(2), 29; https://doi.org/10.3390/pharmacy6020029

Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan

1
Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan
2
Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 84428, Saudi Arabia
3
Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Malaysia
*
Author to whom correspondence should be addressed.
Received: 11 February 2018 / Revised: 27 March 2018 / Accepted: 27 March 2018 / Published: 31 March 2018
(This article belongs to the Special Issue Patient Safety and Adverse Drug Events in Medication Practice)
Full-Text   |   PDF [258 KB, uploaded 3 May 2018]

Abstract

Objectives: Pharmacovigilance in Pakistan needs robust preference in terms of implementation and consistent movement of structured approaches. The objective of this study is to explore the knowledge, attitude and barriers towards adverse drug reaction (ADR) reporting among physicians and pharmacists and to explore the encouraging factors of ADR reporting. Methods: The current research was a cross-sectional study design in which a pre-validated questionnaire was administered to physicians and pharmacists in Abbottabad, Pakistan. The study was conducted for two months from January 2016 to February 2016. Results: A total of 194 physicians and pharmacists responded with a response rate of 35.3%. All the respondents either strongly agreed or agreed that ADRs reporting is a part of their duty. Half of the respondents agreed that monitoring of drug safety is important. Around three quarters of respondents (74.2%) stated that they did not report ADRs due to unavailability of reporting forms while 70% cited lack of a proper pharmacovigilance center as one of the key barriers. Half of the respondents (52.2%) did not report due to their insufficient knowledge. A large majority (81.8%) said that they would report ADRs if there is pharmacovigilance center. On the point of incentives, opinion seems to be divided. Slightly less than half (47.8%) cited their wish to have few incentives while the remaining 52.2% either preferred to be neutral or disagreed. Conclusion: Based on the study findings, barriers were mostly related to general unfamiliarity with ADRs reporting guidelines and the non-existence of a pharmacovigilance center. It is highlighted that the regulatory body should carve a niche for a properly functional pharmacovigilance center and initiate educational programs for strengthening knowledge and attitudes towards ADR reporting. View Full-Text
Keywords: pharmacovigilance; ADR; pharmacist; physician pharmacovigilance; ADR; pharmacist; physician
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Syed, A.; Azhar, S.; Raza, M.M.; Saeed, H.; Jamshed, S.Q. Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan. Pharmacy 2018, 6, 29.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top